학술논문
Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open-label randomised trial
Document Type
Artikel
Author
Yeni, P; Cooper, DA; Aboulker, JP; Babiker, AG; Carey, D; Darbyshire, JH; Floridia, M; Girard, PM; Goodall, L; Hooker, MH; Mijch, A; Meiffredy, V; Salzberger, B; Antunes, F; Babiker, A; Becker, M; Boukli, N; Brun-Vezinet, F; Churchill, D; Conway, B; Chazallon, C; Darbyshire, J; De Wit, S; Dusak, B; Emery, S; Flepp, M; Gatell, J; Goodall, RL; Hemmer, R; Hooker, M; Law, M; Loveday, C; Lundgren, J; Manion, D; Mulcahy, F; Orani, A; Pharo, C; Ristola, M; Sandstrom, E; Schechter, M; Schnittman, S; Seligmann, M; Staszewski, S; Stek, M; Verbiest, W; Weber, J; Withnall, R
Source
Lancet (London, England). 368(9532):287-298
Subject
Language
English
English
English
ISSN
1474-547X